|
|
Volumn 4, Issue 7, 2012, Pages 2306-2310
|
|
Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy
a,b
c
a
b
a
a
b
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTI-TUMOR AGENTS;
CYTOTOXITY;
EQUIVALENT DOSE;
ESTER BONDS;
IN-VITRO;
IN-VIVO;
IRON OXIDE NANOPARTICLE;
MODEL DRUGS;
PACLITAXEL;
PH-DEPENDENT;
SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;
TUMOR IMAGING;
TUMOR SUPPRESSION;
TUMOR TISSUES;
BIOCOMPATIBILITY;
ESTERIFICATION;
ESTERS;
METAL NANOPARTICLES;
SUPERPARAMAGNETISM;
TUMORS;
ANTINEOPLASTIC AGENT;
CONTRAST MEDIUM;
DEXTRAN;
DIAGNOSTIC AGENT;
DRUG CARRIER;
MAGNETITE NANOPARTICLE;
NANOCONJUGATE;
PACLITAXEL;
SUPERPARAMAGNETIC IRON OXIDE;
ANIMAL;
ARTICLE;
BIOLOGICAL MODEL;
CHEMISTRY;
DRUG SCREENING;
HELA CELL;
HUMAN;
INSTITUTE FOR CANCER RESEARCH MOUSE;
METABOLISM;
MOUSE;
NEOPLASM;
SYNTHESIS;
TUMOR CELL LINE;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CONTRAST MEDIA;
DEXTRANS;
DRUG CARRIERS;
HELA CELLS;
HUMANS;
MAGNETITE NANOPARTICLES;
MICE;
MICE, INBRED ICR;
MODELS, BIOLOGICAL;
NANOCONJUGATES;
NEOPLASMS;
PACLITAXEL;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
|
|
EID: 84861864490
PISSN: 20403364
EISSN: 20403372
Source Type: Journal
DOI: 10.1039/c2nr11918h Document Type: Article |
|
Times cited : (33)
|
|
References (14)
|
